Should we ban hydroethyl starches from the operating theatre? PRO

Anaesth Crit Care Pain Med. 2020 Apr;39(2):187-188. doi: 10.1016/j.accpm.2020.03.013. Epub 2020 Mar 14.

Authors

Matthieu Legrand¹, Romain Pirracchio²

Affiliations

¹ Department of Anaesthesiology and perioperative care, University of California San Francisco, San Francisco, CA, United States; UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; INI-CRCT network, Paris, France. Electronic address: matthieu.m.legrand@gmail.com.
² Department of Anaesthesiology and perioperative care, University of California San Francisco, San Francisco, CA, United States.

PMID: 32229269
DOI: 10.1016/j.accpm.2020.03.013

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Kidney Injury*
Elective Surgical Procedures
Humans
Hydroxyethyl Starch Derivatives / adverse effects
Operating Rooms* / organization & administration

Substances

Hydroxyethyl Starch Derivatives